Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158436 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Francesca Tavano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Endoscopy, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotond…. Hauptthemen laut MEDLINE: Mutation, Pancreatic Neoplasms, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Minister of Health, Italian Minister of Health, Ricerca Corrente program 2022–2024, Division of Gastroenterology, Fondazione IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo (FG).
Abstract (Originalsprache)
Diagnosis of biliopancreatic cancers by the available serum tumor markers, imaging, and histopathological tissue specimen examination remains a challenge. Circulating cell-free DNA derived from matched pairs of secretin-stimulated duodenal fluid (DF) and plasma from 10 patients with biliopancreatic diseases and 8 control subjects was analyzed using AmpliSeq™ HD technology for Ion Torrent Next-Generation Sequencing to evaluate the potential of liquid biopsy with DF in biliopancreatic cancers. The median cfDNA concentration was greater in DF-derived than in plasma-derived samples. A total of 13 variants were detected: 11 vs. 1 were exclusive for DF relative to the plasma source, and 1 was shared between the two body fluids. According to the four-tier systems, 10 clinical tier-I–II (76.9%), 1 tier–III (7.7%), and 2 tier–IV (15.4%) variants were identified. Notably, the 11 tier-I-III variants were exclusively found in DF-derived cfDNA from five patients with biliopancreatic cancers, and were detected in seven genes (KRAS, TP53, BRAF, CDKN2A, RNF43, GNAS, and PIK3CA); 82% of the tier-I-III variants had a low abundance, with a VAF < 6%. The mutational profiling of DF seems to be a reliable and promising tool for identifying cancer-associated alterations in malignant cancers of the biliopancreatic tract.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Endoscopy, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy.
- Department of Surgery, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy.
- Department of Oncology, Fondazione IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy.
ORCID-Profile: Francesca Tavano, Orazio Palmieri, Francesco Perri
Förderung
- Italian Minister of Health
- Italian Minister of Health, Ricerca Corrente program 2022–2024
- Division of Gastroenterology, Fondazione IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo (FG)
- “5 × 1000” voluntary contribution
Zitieren
APA
Tavano, F., Latiano, A., Palmieri, O., Gioffreda, D., Latiano, T., Gentile, A., Tardio, M., Latiano, T. P., Gentile, M., Terracciano, F., & Perri, F. (2024). Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158436
Vancouver
Tavano F, Latiano A, Palmieri O, Gioffreda D, Latiano T, Gentile A, et al. Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158436
BibTeX
@article{Tavano2024,
author = {Tavano, Francesca and Latiano, Anna and Palmieri, Orazio and Gioffreda, Domenica and Latiano, Tiziana and Gentile, Annamaria and Tardio, Matteo and Latiano, Tiziana Pia and Gentile, Marco and Terracciano, Fulvia and Perri, Francesco},
title = {Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158436}
}
EUVIMED